71 related articles for article (PubMed ID: 4774187)
1. Are class 1 and class 2 Pap smears objectively interpreted?
Berube LW
Md State Med J; 1973 Sep; 22(9):54-8. PubMed ID: 4774187
[No Abstract] [Full Text] [Related]
2. Companies build Pap smear safety nets.
Scott L
Mod Healthc; 1995 May; 25(19):70. PubMed ID: 10142267
[No Abstract] [Full Text] [Related]
3. Pap smear concerns.
Moran T
Tex Med; 1997 Nov; 93(11):44-6. PubMed ID: 9369088
[No Abstract] [Full Text] [Related]
4. Pap smear furor may derail Clinton changes.
Scott L
Mod Healthc; 1993 Oct; 23(40):17. PubMed ID: 10171532
[No Abstract] [Full Text] [Related]
5. Random rescreening of cytologic smears: a practical and effective component of quality assurance programs in both large and small cytology laboratories.
Krieger P; Naryshkin S
Acta Cytol; 1994; 38(3):291-8. PubMed ID: 8191815
[No Abstract] [Full Text] [Related]
6. [External quality control in cervical cytopathology: an evaluation from 2000-2004].
Rev Saude Publica; 2007 Dec; 41(6):1071. PubMed ID: 18066478
[No Abstract] [Full Text] [Related]
7. Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smears.
Arbyn M; Schenck U; Ellison E; Hanselaar A
Cancer; 2003 Feb; 99(1):9-16. PubMed ID: 12589640
[TBL] [Abstract][Full Text] [Related]
8. Quality evaluation of cytology laboratories in New York State: expanded program, 1971-73.
Collins DN; Kaufmann W; Clinton W
Acta Cytol; 1974; 18(5):404-13. PubMed ID: 4140649
[No Abstract] [Full Text] [Related]
9. European guidelines on cervical screening.
Smith JH; Desai MS
Cytopathology; 2007 Aug; 18(4):211-2. PubMed ID: 17635160
[No Abstract] [Full Text] [Related]
10. Effect of the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88).
Austin RM
Med Care; 1994 Oct; 32(10):1064-5. PubMed ID: 7934273
[No Abstract] [Full Text] [Related]
11. Study proposes Pap smears at 3-year intervals.
AIDS Read; 2000 Nov; 10(11):643. PubMed ID: 11186186
[No Abstract] [Full Text] [Related]
12. [Cervical smears and evaluation of quality].
Marsan C
Ann Pathol; 1996 Nov; 16(5):344-9. PubMed ID: 9004721
[No Abstract] [Full Text] [Related]
13. The adequacy of Papanicolaou smears as performed by family physicians and obstetrician-gynecologists.
Fiscella K; Franks P
J Fam Pract; 1999 Apr; 48(4):294-8. PubMed ID: 10229255
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
[TBL] [Abstract][Full Text] [Related]
15. Does a zero error standard exist for the Papanicolaou smear? A pathologist's perspective.
Frable WJ
Arch Pathol Lab Med; 1997 Mar; 121(3):301-10. PubMed ID: 9111124
[TBL] [Abstract][Full Text] [Related]
16. [Cervical screening--its essence and quality-control methodology in cytology laboratories].
Kostova P
Akush Ginekol (Sofiia); 1998; 37(4):58-61. PubMed ID: 10360060
[TBL] [Abstract][Full Text] [Related]
17. Optimal collection technique and devices for a quality pap smear.
Marchand L; Mundt M; Klein G; Agarwal SC
WMJ; 2005 Aug; 104(6):51-5. PubMed ID: 16218317
[TBL] [Abstract][Full Text] [Related]
18. The effect of the quality of Papanicolaou smears on the detection of cytologic abnormalities.
Mintzer M; Curtis P; Resnick JC; Morrell D
Cancer; 1999 Jun; 87(3):113-7. PubMed ID: 10385441
[TBL] [Abstract][Full Text] [Related]
19. Pap smears: quality, not only quantity.
Ward J; Farnsworth A; Grace J; Ford J
Aust Fam Physician; 1990 Feb; 19(2):109. PubMed ID: 2322178
[No Abstract] [Full Text] [Related]
20. Patient age and adequacy of Pap smears.
Aaen V; Ferry L
Am Fam Physician; 1993 Feb; 47(3):585-6, 588. PubMed ID: 8434549
[No Abstract] [Full Text] [Related]
[Next] [New Search]
